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Chemoattractants provoke monocyte adhesion to human
mesangial cells and mesangial cell injury
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DEBORAH PALLISER, and BARRY M. BRENNER
Renal Division, Department of Medicine, Brigham & Women's Hospital and Harvard Center for the Study of Kidney Disease, Harvard
Medical School, Boston, Massachusetts, USA
Chemoattractants provoke monocyte adhesion to human mesangial
cells and mesangial cell injury. Infiltration of glomerular mesangium by
monocytes/macrophages is a prominent pathologic finding in many
forms of glomerulonephritis (GN). While the mechanism(s) by which
infiltration occurs is incompletely understood, monocyte adhesion to
glomerular endothelial cells, provoked by inflammatory mediators,
appears to be an important early step. In the present study, we assessed
the influence of chemotactic peptides (C5a) and lipids (LTB4 and PAF)
on adhesion of human monocytes and mesangial cells, to determine if
mesangial cells (glomerular pericytes with smooth muscle properties)
represent potential targets for adhesion of chenioattractant-activated
monocytes following their diapedesis from the intravascular space. C5a
and LTB4 provoked rapid (onset <I mm) monocyte-mesangial cell
adhesion at nanomolar concentrations via actions with monocytes,
while PAF was less potent in this regard. Monoclonal antibodies (mAb)
were used to define the monocyte and mesangial cell adhesion mole-
cules involved in these interactions. C5a- and LTB4-induced monocyte
adhesion was inhibited (—54%) by mAb against the common beta CDI8
subunit of CDI 1/CD 18 leukocyte integrins, while mAb against mono-
cyte L-selectin was without effect. MAb against unique CD11 subunits
were used to determine the relative contributions of different CD1 1/
CDI8 integrins. In this regard, adhesion was inhibited by mAb against
CDllb (——41%), and CDlIc (—23%), but not CDIIa. MAb against
mesangial cell ICAM-l afforded -—27% reduction in adhesion, while
mAb against VCAM-l, E-selectin, and P-selectin were without effect.
GM-CSF, a cytokine generated by monocytes and mesangial cells, also
provoked CDI I/CD 18-dependent adhesion, and primed monocytes to
the actions of chemoattractants. Furthermore, priming of monocytes
with GM-CSF appeared to promote mesangial cell injury during subse-
quent monocyte-mesangial cell coincubations. The adhesion-promoting
actions of chemoattractants with monocytes were additive with those of
cytokines with mesangial cells (that is, TNF-induced ICAM-l and
VCAM-1 expression). These data indicate that mesangial cells support
adhesion of monocytes in vitro, and that chemotactic peptides and
lipids act in concert with cytokines to promote adhesion and mesangial
cell injury. Mesangial cells may be targets for monocyte adhesion in
vivo and regulate monocyte trafficking during glomerular inflammation.
Monocytes/macrophages and neutrophils (phagocytes) infil-
trate glomeruli early in acute glomerrtlonephritis (GN) and
appear to be important mediators of glomerular injury 1—9,
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reviewed in 3—5]. The mechanisms by which phagocytes infil-
trate glomeruli under these circumstances are incompletely
understood. Phagocyte trafficking to sites of inflammation ap-
pears to involve several coordinated steps: chemotaxis along a
concentration gradient of chemoattractant, adhesion to endo-
thelial cells, diapedesis between endothelial cells, continued
migration through extravascular tissue, and interaction with
resident tissue cells. Adhesion occurs via specific interaction of
phagocyte adhesion molecules with counter-receptors on endo-
thelial cells [reviewed in 10—161. Adhesion molecule expression
is regulated at several levels [reviewed in 10—16]. Phagocytes,
upon activation, display increased adhesiveness for endothelial
cells due to a change in avidity of constitutively expressed
adhesion molecules (such as CD1I/CD18 integrins or L-selec-
tin) for endothelial cell ligands [10, 11, 14, 151. In contrast,
endothelial cell adhesiveness for phagocytes is increased within
minutes upon exposure to mediators such as histamine or
thrombin, as preformed adhesion molecules (such as P-selectin)
are mobilized from subcellular granules to the cell surface [15].
Prolonged exposure of endothelial cells [16], including glomer-
ular endothelial cells [171 (hours—days) to cytokines, such as
TNF alpha or interleukin-I beta, also promotes adhesion by
inducing de novo synthesis of endothelial cell ligands [for
example, E-selectin (formerly ELAM-1), ICAM-l, and YCAM-
11.
Initial adhesion of phagocytes to endothelial cells in vivo is
mediated by interaction of phagocyte L-selectin (formerly
LAM-I, LEC-CAM- 1, LECAM- 1, human homologue of Mel-
14), or endothelial cell P-selectin (formerly GMP-140, PAD-
GEM) or E-selectin (formerly ELAM-1) with carbohydrate-
containing counter-receptors [15]. Selectin-mediated adhesion
appears insufficient to completely arrest phagocyte movement,
but supports phagocyte rolling on the endothelial wall [15].
These events, in turn, facilitate immobilization by engagement
of phagocyte integrins (VLA-4 beta-i and CDI 1/CD 18 beta-2)
with immunoglobulin-like (Ig-like) molecules on endothelial
cells (VCAM-I and ICAM-l, respectively), and subsequent
diapedesis into extravascular tissue [10, 11, 13, 14].
While the molecular basis for phagocyte-endothelial cell
adhesion has been relatively well-defined, the mechanisms by
which phagocytes interact with other resident cells following
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diapedesis are incompletely understood. These events may
determine the ultimate fate of migrating phagocytes during
inflammation. In acute glomerulonephritis, neutrophils and
monocytes are seen within glomerular capillaries, while mono-
cytes predominate within the glomerular mesangium [3]. These
observations suggest that mesangial cells may regulate mono-
cyte trafficking by elaborating monocyte chemoattractants
and/or by supporting adhesion of chemoattractant-activated
monocytes. The present study was designed to explore the
latter possibility. We assessed monocyte adhesion to monolay-
ers of mesangial cells in vitro as a model of glomerular inflam-
mation. We studied the influence of chemoattractant lipids
(LTB4 and PAF) and peptides (C5a) on this process since these
mediators are generated by inflammed glomeruli [4—9] and are
potent stimuli for leukocyte adhesion to endothelial cells [10,
12, 18]. Monoclonal antibodies (mAb) were used to define the
relative roles of integrin, selectin, and Ig-like adhesion mole-
cules in these events. Mesangial cell integrity was monitored
during phagocyte-mesangial cell interaction. Finally, the poten-
tial interactions of peptide or lipid chemoattractants and cyto-
kines in promoting adhesion were examined.
Methods
Preparation of human monocytes
Monocytes were isolated from anticoagulated venous blood
drawn from normal volunteers by standard techniques of Ficoll-
Hypaque (Mono-Poly Resolving Medium, ICN Biomedicals,
Costa Mesa, California, USA) gradient centrifugation followed
by dextran sedimentation, by slight modification of previously
published methods [19—21]. Contaminating red cells were re-
moved by hypotonic lysis. These suspensions contained 85 to
95% monocytes, as determined by light microscopy and stain-
ing for nonspecific esterase. The integrity of cells in suspension
was monitored by determining exclusion of trypan blue. Sus-
pensions in which less than 3% of cells were permeable to
trypan blue were used for studies of adhesion.
Human mesangial cells
Human mesangial cells were cultured from glomeruli isolated
from a healthy cadaveric kidney which could not be used for
transplantation, and were characterized according to their
morphology and pattern of staining with antibodies against
myosin light chain, cytokeratin, and Factor VIII antigen, as
previously described [21, 221. Mesangial cells were propagated
in RPM! 1640 containing 15% supplemented calf serum (SCS)
on gelatin coated plastic tissue culture plates (Costar, Massa-
chusetts, USA). Mesangial cells (passage levels 4-13) which had
been grown to confluence on 24-well gelatin-coated plastic
tissue culture plates (Costar) were used in adhesion experi-
ments.
Monocyte-mesangial cell adhesion
Monocyte-mesangial cell adhesion was assayed using a quan-
titative in vitro monolayer adhesion assay, by slight modifica-
tion of published methods [20, 21, 23]. Briefly, monolayers were
washed with Dulbecco's phosphate-buffered saline containing
1% SCS (PBS-SCS). Monocytes were radiolabeled with min
dium-oxine (Amersham; I to 2 tCi/106 cells for 30 mm at room
temperature) and then washed three times in PBS-SCS to
remove extracellular "indium-oxine. Monocyte preparations,
in which clumping was observed by microscopy following
labelling with "indium, were discarded. Monocytes were
added to washed mesangial cell monolayers at a final density of
2 x 106 cells/well (final volume 0.5 mI/well) and coincubated at
37°C in a humidified atmosphere containing 5% C02-95% air.
Monocytes were allowed to settle for 10 minutes prior to
addition of chemoattractants. After coincubations, medium
containing non-adherent monocytes was removed by aspira-
tion, and monolayers were washed gently with PBS-SCS and
assessed by light microscopy. The contents of each well were
solubilized with a solution containing 0,01% sodium docyl
sulphate and 2 mivi NaOH, and the radioactivity was measured
in a gamma counter (LKB-Wallac Clinigamma). The number of
adherent monocytes (adherent cells/mm2 of mesangial cell
monolayer) was calculated from the specific activity of each
monocyte preparation. Individual data points represent means
of four wells. For each experiment, chemoattractant-induced
adhesion was calculated by subtraction of adhesion observed
with vehicle-treated controls.
Reagents and monoclonal antibodies (mAb)
Leukotriene B4 was purchased from Biomol Research Labo-
ratories (Philadelphia, Pennsylvania, USA) and the concentra-
tion of stock solutions were determined by UV spectroscopy
from its extinction coefficient, before incubation with cells. C5a
and PAF were purchased from Sigma Chemical Co. (St. Louis,
Missouri, USA). LTB4 and PAF were stored in ethanol, and
final ethanol concentrations following addition of these com-
pounds to monocyte-mesangial cell coincubations were <0.1%.
Recombinant human GM-CSF was purchased from Genzyme
(Framingham, Massachusetts, USA). Recombinant human tu-
mor necrosis factor alpha (TNF) and interleukin-l beta (IL-i)
were obtained from Knoll Pharmaceuticals (Whippany, New
Jersey, USA) and R & D (Minneapolis, Minnesota, USA),
respectively. Working cell culture media and stock solutions of
LTB4, PAF, C5a, GM-CSF, IL-I, and TNF contained <2 pg/mI
of endotoxin, as determined by a semiquantitative E-toxate kit
(Sigma). The following mAb have been shown to block leuko-
cyte adhesion to endothelial cells mediated by CD11/CD18 or
L-selectin and were used to define the role of monocyte
adhesion molecules in monocyte-mesangial cell adhesion: mAb
TS1/18 (IgGl) recognizes the common beta CD18 subunit of
CDI l/CD18 integrin adhesion molecules; mAb TS1/22 (IgGI)
recognizes CDlia (LFA-l); and LM2/i recognizes CD11b
(Mac-i, Mol) [18, 24, 251. These were gifts from Dr. R.
Rothlein, Boehringer Ingelheim Pharmaceuticals (Ridgefield,
Connecticut, USA). MAb CBRp15O (IgGl) recognizes CDllc
(p159,95, Leu-M5) [26], and was a gift from Drs. S. Stacker
and T.A. Springer, Harvard Medical School. Mab LAM 1.3
recognizes a functional epitope on L-selectin and was a gift
from Dr. T.F. Tedder, Harvard Medical School [27]. The
following mAb have been shown to inhibit E-selectin, ICAM-l,
and VCAM-1 mediated phagocyte-endothelial cell adhesion and
were used to define the mesangial cell adhesion molecules
involved in chemoattractant-stimulated monocyte-mesangial
cell adhesion: murine mAb Hu5/3 (Fab IgGI), H18/7 (IgG2a)
and EI/6 (IgGi) recognize functional epitopes on !CAM-l,
Fig. 1. LTB4 (0), C5a (•), and to a lesser extent PAF (U), provoke adhesion of human monocytes to monolayers of human mesangial cells. (A)
Studies of time-dependence in which monocytes were coincubated with mesangial cell monolayers for I to 30 minutes in the presence of iO M
concentrations of chemoattractant and adhesion was assessed. (B) Studies of concentration-dependence in which monocytes were coincubated
with mesangial cell monolayers for 30 minutes in the presence of different concentrations of chemoattractant, and adhesion was assessed.
Chemoattractant-stimulated adhesion was calculated by subtraction of adhesion with vehicle-treated controls. Data are means SE of 9
experiments, each conducted in quadruplicate.
E-selectin, and VCAM-1, respectively, and were giftsf rom Drs.
F.W. Luscinskas and M. Cybulsky, Harvard Medical School
[28—30]. Anti-p-selectin (GMP- 140, PADGEM) was a gift from
Dr. E. Larsen, Dartmouth University. Saturating concentra-
tions of mAb were used in all studies of moriocyte adhesion and
adhesion molecule surface expression, and were determined by
either FACS analysis (with activated monocytes) or indirect
immunofluorescence (with TNF-activated mesangial cells and
TNF-activated human umbilical vein endothelial cells).
Determination of adhesion molecule surface expression by
indirect immunofluorescence
Surface expression of adhesion molecules on mesangial cells
was assessed with monolayers grown to confluence on gelatin
coated 96-well tissue culture plates (Costar), as described
previously [21]. Briefly, monolayers were incubated with satu-
rating concentrations of control or test mAb on PBS/l0% SCS
at 4°C for one hour, followed by washing three times with
PBS/lO% SCS, and incubation with FITC-labeled F(ab')2 goat
anti-murine IgG (Caltag Laboratories, San Francisco, Califor-
nia, USA) at 4°C for one hour. The contents of each well were
washed three times with PBS/lO% SCS, solubilized with 0.1%
SDSI2 ms NaOH, and transferred to Dynatech 96-well micro-
titer plate (Dynatech, Massachusetts, USA) for measurement of
immunofluorescence with an automated fluorimeter microtiter
plate reader (Pandex, Baxter Healthcare).
51Chromium release from mesangial cells
51Cr release from radiolabeled mesangial cell monolayers was
monitored as an index of mesangial cell injury during monocyte-
mesangial cell coincubations [21]. Mesangial cell monolayers
were radiolabeled by incubation for 18 hours in I ml of RPM!
1640 medium containing 15% SCS, 100 U/mI penicillin, 100
jsg/ml streptomycin, and 5 pCi5Cr. The monolayers were
washed four times with PBS/l% SCS, and coincubated at 37°C
with monocytes that were not labeled with mindium, Results
were expressed as a percentage of 5tchromium release follow-
ing addition of digitonin.
Statistical analysis
Data are means SE of at least three adhesion experiments.
Statistical significance was determined by use of Student's
t-test or ANOVA. A value of P < 0.05 was taken to represent
a statistically significant difference between group means.
Results
Adhesion of human monocytes to human mesangial cells:
Influence of C5a, LTB4 and PAF
Human monocytes were coincubated with monolayers of
human mesangial cells for 30 minutes and adhesion was as-
sessed. Basal monocyte adhesion under these conditions was 69
16 cells/mm2 (N = 9). A marked increase in monocyte-
mesangial cell adhesion was noted when either LTB4 (l0— M)
or C5a (l0— M) was added to coincubations (chemoattractant-
induced monocyte adhesion in cells/mm2: LTB4 134 17, C5a
203 21, N = 9). PAF (l0 M) also induced adhesion, but to
a lesser degree than other agonists (37 17, N = 9). Figure 1
shows the time (Fig. 1A) and concentration (Fig. 1B) depen-
dence of these responses. Adhesion was rapid in onset, begin-
fling within five minutes of exposure, and was sustained for up
to thirty minutes. Monocyte-mesangial cell adhesion was pro-
voked with C5a and LTB4 concentrations as low as i0 M, and
maximum adhesion were observed with doses of i0 M or
greater. In contrast, significant monocyte adhesion was only
observed with PAF concentrations of i0— M and above (Fig.
IB). These data indicated that LTB4 and C5a, and to a lesser
extent PAF, are potent stimuli of monocyte adhesion to mono-
layers of human mesangial cells. LTB4 and C5a-induced adhe-
sion were assessed in greater detail to determine the mechanism
and consequences of these interactions.
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Fig. 2. LTB4- and C5a-stimulated monocyte adhesion to mesangial cell monolayers: Assessment of contributions of CDIJICDJ8 integrins and
L-selectin. (A) influence of control (U), anti-CDI8(PA, mAb TSI/18), and anti-L-selectin (0, anti-LAM 1-3 mAb) blocking monoclonal antibodies.
(B) Assessment of relative roles of individual CD1I/CDI8 integrins using blocking monoclonal antibodies against CDI Ia (mAb TSI/22), CDIIb
(mAb LM2II), and CD1Ic (mAb CBRp 150). Monocytes were incubated with saturating concentrations of monoclonal antibodies (see Methods) for
20 minutes at room temperature prior to coincubation with mesangial cell monolayers in the presence of l0— M concentrations of chemoattractant.
Data are means SE of 6 to Il experiments, each conducted in quadruplicate.
To determine whether LTB4 and C5a provoked adhesion via
actions with monocytes or mesangial cells, adhesion was as-
sessed following fixation of either monocytes or mesangial cells
with PBS/1% paraformaldehyde. Significant stimulation of
monocyte-mesangial cell adhesion (LTB4 68 17, C5a 71 13)
was observed following coincubation of viable monocytes with
paraformaldehyde-fixed mesangial cells for 30 minutes in the
presence of i0 M concentrations of chemoattractant. In
contrast, these compounds did not provoke adhesion of para-
formaldehyde-fixed monocytes and viable mesangial cells.
Taken together, these data suggested that LTB4 and C5a
stimulate monocyte-mesangial cell adhesion via actions with
monocytes.
Monocyte-mesangial cell adhesion: Role of integrin, selectin
and Ig-like adhesion molecules
Monocyte-endothelial cell adhesion is mediated, in large part,
by interaction of monocyte VLA-4 beta-i or CDI l/CDI8 beta-2
integrins with Ig-like molecules on endothelial cells (VCAM-l
and ICAM-l, respectively), or by interaction of monocyte
L-selectin, or endothelial cell P-selectin or E-selectin with
carbohydrate-containing counter-receptors [reviewed in 10—16].
Monoclonal antibodies were used to define the relative contri-
butions of these molecules to adhesion of LTB4- or C5a-
activated monocytes to mesangial cell monolayers. The results
are shown in Figure 2A. MAb (TSI/18) against the common
beta CDI8 subunit of CDI 1/CD18 beta-2 integrins caused a
marked reduction (—54% inhibition) of LTB4- and C5a-induced
adhesion. In contrast, adhesion was not altered by mAb (anti-
LAM 1-3 mAb) against L-selectin. Three CD1 1/CD 18 integrins
have been described: CDI la/CD18 (LFA-1), CDI lb/CDI8
(Mac-i, Mol) and CDI lc/CDI8 (p150,95) [reviewed in 10].
These molecules differ in the structure of their alpha CD1 1
subunits, which exist noncovalently bound to a common CDI8
subunit [10]. MAb against CD! I subunits were used to define
the relative contributions of individual CDI I/CD 18 molecules
to chemoattractant-stimulated monocyte-mesangial cell adhe-
sion (Fig. 2B). MAb (LM2/l) against functional adhesion
epitopes on CD1 lb afforded significant inhibition of LTB4 and
C5a-induced adhesion (—41% inhibition). In contrast, mAb
(OKMI) against a silent epitope on this molecule did not
influence adhesion. MAb (CBRpI5O) against CDI Ic also re-
duced adhesion (—24% inhibition). In contrast, mAb (TS1/22)
against CDlla was without effect.
Since ICAM-1 is a major endothelial cell ligand for CD! 1/
CD18 [10, 11], including CD1!b/CDI8 [31], anti-ICAM-l mAb
(Hu5/3) was used to define the role of this molecule in chemoat-
tractant-stimulated monocyte-mesangial cell adhesion. MAb
against ICAM-1 inhibited the actions of LTB4 and C5a by 28
10 and 21 12%, respectively (Fig. 3). In contrast, mAb against
VCAM-l (El.6), E-selectin (H18/7), and P-selectin did not
influence these events, when used alone (Fig. 3) or in combi-
nation with anti-ICAM-l mAb (data not shown).
These data suggested that CDllb/CDI8 is an important
monocyte ligand mediating adhesion of chemoattractant-stimu-
lated monocytes to monolayers of human mesangial cells. To
explore this possibility further, chemoattractant-stimuiated ad-
hesion was assessed at 4°C, since CD1 1/CD 18-mediated adhe-
sion to a variety of substrates is known to be reduced under
these conditions, while adhesion through other monocyte Ii-
gands (such as L-selectin and VLA-4) remains functional. The
results are shown in Table 1. CSa- and LTB4-stimulated adhe-
sion was dramatically reduced at 4°C (---41%), providing further
evidence for involvement of CD1 1/CD 18 integrins.
Since mesangial cells may themselves possess phagocytic
properties, and thus could potentially express CD1 1/CD18, we
assessed surface expression of these ligands on mesangial cells
by indirect immunofluorescence using anti-CD 18 mAb. Mesan-
gial cells did not express CDI l/CD18 integrins under basal
conditions or following exposure to C5a or LTB4 (not shown).
In contrast, expression of CDI 1/CDI8, which was increased in
J;2T
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Fig. 3. LTB4- and GSa-stimulated monocyte adhesion to mesangial
cell mono/ayers: Assessment of roles of Ig-like and selectin adhesion
molecules. Mesangial cell monolayers were incubated with saturating
concentrations of monoclonal antibodies against either ICAM- I (,
mAbHu5/3), VCAM-1 (0, mAb EI/6), P-selectin (El), or E-selectin(,
mAb Hl8/7) or control (•) for 20 minutes at room temperature (see
Methods), prior to coincubation with monocytes in the presence of io-
M concentrations of chemoattractant. Data are means s of 4 to 10
experiments, each conducted in quadruplicate.
response to chemoattractants, was observed with monocytes,
as has been observed previously by other investigators [10].
GM-CSF provokes monocyte-mesangial cell adhesion and
primes monocytes to adhesion-promoting actions of
chemoattractants
GM-CSF is a cytokine generated by a variety of cells,
including monocytes and mesangial cells [32], that has been
shown to provoke CD1 1/CD 18-mediated leukocyte adhesion in
vitro [33]. Since GM-CSF levels are elevated in the glomerulus
in acute glomerulonephritis [32], we sought to determine if this
cytokine influences monocyte adhesion to mesangial cell mono-
layers. To this end, monocyte-mesangial cell adhesion was
assessed following coincubation for 30 minutes in the presence
of 100 p recombinant human GM-CSF. This cytokine pro-
voked a dramatic increase in monocyte adhesion under these
conditions (GM-CSF-induced adhesion in monocytes bound/
mm2: 131 24, N 5). Adhesion was determined in the
presence of anti-CDI8 mAb to define the role of CD11/CDI8
integrins in this response. Anti-CD18 mAb inhibited adhesion
by 77 18% (N 6) under these conditions, suggesting that
this was in part a CD1I/CD18-dependent event.
Prolonged exposure of phagocytic leukocytes to subpicomo-
lar concentrations of GM-CSF primes several phagocyte re-
sponses (such as generation of lipoxygenase products and
superoxide anion) to a variety of chemoattractants [34, 35].
Given these observations, we assessed the effect of priming
doses of GM-CSF on LTB4- and C5a-stimulated monocyte-
mesangial cell adhesion. Monocytes were incubated with 1.0
M GM-CSF for 90 minutes at 37°C, followed by coincubation
with mesangial cell monolayers for 30 minutes in the presence
or absence of i07 M C5a, and adhesion was assessed, GM-CSF
alone, at this concentration, did not provoke monocyte adhe-
sion (Fig. 4A). However, CSa-stimulated monocyte-mesangial
cell adhesion was significantly greater with GM-CSF-primed
monocytes, than with sham-primed controls. Similar results
Table 1. Monocyte-mesangial cell adhesion: Temperature
dependence
Chemoattractant
cells/mm2
37°C 4°C
LTB4 106± 22 56± 9
CSa 179± 34 52± 16
Monocytes were coincubated with mesangial cell monolayers for 30
mm at either 37°C or 4°C in the presence of i0 M concentration of
LTB4 or CSa. Chemoattractant stimulated adhesion was calculated by
subtraction of adhesion with vehicle-treated controls. Data are means
SE of 4 experiments, each conducted in quadruplicate.
were obtained with LTB4 (data not shown). Since GM-CSF
may also influence mesangial cell function, monocyte-mesan-
gial cell adhesion was assessed following GM-CSF priming of
mesangial cell monolayers (1.0 pvi GM-CSF for 90 mm).
GM-CSF did not increase mesangial cell adhesiveness for
monocytes during subsequent coincubations (C5a-induced ad-
hesion in monocytes bound/mm2: sham-primed mesangial cells
186 23, GM-CSF-primed mesangial cells 204 12, N = 3).
Mesangial cell injury during monocyte-mesangial cell
interaction
release from radiolabeled mesangial cells was
monitored during monocyte-mesangial cell interaction as an
index of mesangial cell injury. Figure 4B shows 51chromium
release from mesangial cells during coincubation with mono-
cytes in the presence of C5a (l0 M) or GM-CSF (1.0 pM).
Coincubation of GM-CSF-primed monocytes with mesangial
cells did not result in increased 51chromium release when
compared to sham-primed controls. In contrast, exagerated
51chromium release was observed during coincubations of
sham-primed monocytes with mesangial cells in the presence of
C5a (l0— M), and this process was significantly increased if
monocytes had been primed with GM-CSF.
Monocyte-directed actions of LTB4 and C5a are additive with
actions of cytokines on mesangial cells
We have demonstrated previously that cytokines such as
tumor necrosis factor alpha and interleukin-l beta increase
mesangial cell adhesiveness for monocytes by inducing biosyn-
thesis and increased surface expression of ICAM-l (21] and
VCAM-l [36], Accordingly, we assessed whether these actions
of cytokines with mesangial cells were additive with those of
LTB4 and C5a with monocytes. To this end, mesangial cells
were treated with TNF (100 ng!ml) or IL-I (25 ng/ml) for 24
hours and washed three times with PBS/l% SCS, prior to
coincubation with monocytes in the presence or absence of
iO M concentrations of each chemoattractant. Monocyte-
mesangial cell adhesion was significantly increased by exposure
of mesangial cell monolayers to TNF or IL-l, prior to coincu-
bation with monocytes (30 mm), and a further increase in
adhesion was observed if LTB4 or C5a (lfr7 M) was added to
these coincubations (Table 2).
Discussion
The results of these studies indicate that peptide and lipid
chemoattractants act in concert with cytokines in vitro to
promote monocyte-mesangial cell adhesion and mesangial cell
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Fig. 4. GM-CSF primes monocytes to the adhesion-promoting actions of chemoattractants, and promotes mesangia! cell injury during
monocyte-mesangial cell coincubation. (A) Studies of monocyte-mesangial cell adhesion in which adhesion was assessed following 30 minutes of
coincubation of (a) GM-CSF-primed monocytes (1.0 pM for 90 mm at 37°C) and mesangial cell monolayers, (b) sham-primed monocytes and
mesangial cell monolayers and IO M C5a, or (c) GM-CSF-primed monocytes and mesangial cell monolayers and l0- M C5a. GM-CSF-induced
and C5a-induced adhesion was calculated by subtraction of adhesion with vehicle-treated controls. Data represent mean SE of 6 experiments,
each conducted in quadruplicate. (B) Studies of mesangial cell integrity in which 51chromium release from mesangial cells was monitored during
coincubation with C5a-activated monocytes. Mesangial cell monolayers were labeled for 24 hours with 51chromium (see Methods) prior to
coincubation either (a) GM-CSF-primed monocytes (1.0 M for 90 mm at 37°C), (b) sham-primed monocytes and C5a l0 M, or (c)
GM-CSF-primed monocytes and l0 M C5a. Results are expressed as a percentage of51chromium release observed following addition of digitonin.
Data represent means SE of 6 experiments each conducted in quadruplicate.
cells
cells/mm2
Chemoattractant Vehicle TNF IL-I
Vehicle 45 17 139 22 97 22
LTB4 146 9 249 19° 202 l4'
C5a 197 31 294 19° 302 27°
Mesangial cell monolayers were incubated with either, TNF (100
ng/ml), IL-l (25 ng/ml) or vehicle for 24 hours, washed three times with
PBS/l% SCS and coincubated with monocytes and chemoattractant
(10 M) for 30 minutes. Data are mean SE of 5 experiments, each
conducted in quadruplicate.
a P < 0.05 vs chemoattractant or cytokine alone.
injury. LTB4 and C5a provoked rapid monocyte-mesangial cell
adhesion at concentrations as low as jQ9 M (Fig. 1), Increased
adhesion was still observed after fixation of mesangial cells with
paraformaldehyde, but not if monocytes were fixed. These data
indicate that LTB4 and C5a provoked adhesion via actions with
monocytes, and are consistent with previous studies document-
ing the potency of these mediators as activators of phagocytic
leukocytes. The results provide further evidence that LTB4 and
C5a are important inflammatory mediators in acute GN [4, 5].
Activation of complement and intraglomerular complement
deposition are early events in many forms of GN, and prior
depletion of animals of complement dramatically attenuates the
severity of renal injury in some models of experimental GN [5,
37]. Glomerular LTB4 levels are also increased in acute GN [4,
37], and renal injury can be significantly reduced by prior
treatment of animals with inhibitors of leukotriene biosynthesis
[7]. Interestingly, PAF, another lipid mediator whose levels are
known to be increased in inflamed glomeruli and which appears
to be involved in the pathophysiology of acute GN [6, 8, 9],
appeared to be less potent in promoting monocyte-mesangial
cell adhesion. This mediator only induced adhesion at concen-
trations of 1O M or higher. PAF is a potent stimulus for
neutrophil adhesion to glomerular endothelial cells and mesan-
gial cells (HRB, unpublished observation). Taken together,
these data indicate that PAF may preferentially provoke neu-
trophil adhesion to glomerular cells in vivo.
C5a and LTB4-induced adhesion were studied in greater
detail to further define the mechanism(s) of monocyte-mesan-
gial cell adhesion. In the present study, C5a- and LTB4-induced
adhesion was inhibited, in part, by mAb antibodies against
CDI 1/CD 18 beta-2 integrins (Fig. 2) and ICAM-I (Fig. 3). MAb
against CDI Ib/CDI8, and to a lesser extent CD1Ic/CD18 were
most potent in this regard, while mAb against CDlla did not
influence adhesion. ICAM-l is a counter-receptor for CD! lb
[31]. However, mAb against ICAM-l were less potent inhibi-
tors of monocyte adhesion than mAb against CDI lb. These
results suggest that mesangial cell monolayers express other
ligands for CDllb binding. Since adhesion was assessed with
confluent monolayers of mesangial cells, it seems likely that
these ligands are expressed on mesangial cells. However, one
cannot exclude possible interaction of monocyte CDI lb with
components of mesangial cell matrix either following retraction
of mesangial cells during coincubations, or after diapedesis of
monocytes between mesangial cells. Indeed, monocytes have
been shown to bind avidly to endothelial cell basement mem-
brane components under similar circumstances [381.
The inhibitory effects of anti-CD 1 ic mAb (Fig. 2), albeit
small in magnitude compared to anti-CD! lb mAb, are notewor-
thy and suggest that monolayers of unstimulated mesangial cells
also express counter-receptors for this leukocyte ligand. In-
deed, mesangial cells differ from endothelial cells in this regard.
Table 2. Adhesion-promoting actions of LTB4 and C5a on
monocytes are additive with actions of TNF and IL-I on mesangial
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Anti-CD11c mAb do not inhibit adhesion of activated mono-
cytes to endothelial cells [39], and the latter require activation
by cytokines for expression of CD11c counter-receptors [26].
These data suggest a role for CD1Ic in monocyte adhesion to
mesangial cells during glomerular inflammation, and possibly in
monocyte adhesion to pericytes and smooth muscle cells in
other tissues.
We have recently demonstrated that selectin adhesion mole-
cules, in particular L-selectin, support adhesion of neutrophils
and monocytes to glomerular endothelial cells under simulated
flow conditions [40]. MAb against monocyte L-selectin did not
block monocyte-mesangial cell adhesion in the static adhesion
assay used in this study (Fig. 2). Furthermore, anti-L-selectin
mAb do not appear to influence adhesion of monocytes to
unstimulated or cytokine-activated (TNF 100 ng/ml, 24 hr)
mesangial cells under simulated flow conditions (HRB, unpub-
lished observations). Similarly, mAb against P-selectin and
E-selectin did not inhibit monocyte-mesangial cell adhesion in
the present study (Fig. 3). Consistent with these observations,
we have been unable to demonstrate surface expression of
either P- or E-selectin on unstimulated mesangial cell monolay-
ers or following exposure to histamine or cytokines, as deter-
mined by indirect immunofluorescence (data not shown). Taken
together, these findings suggest that selectins do not play a
major role in monocyte-mesangial cell adhesion. These data are
consistent with the hypothesis that selectin-mediated leuko-
cyte-endothelial adhesion slows circulating leukocytes and fa-
cilitates diapedesis [13, 15], but that these interactions may not
be necessary following migration of leukocytes into the ex-
travascular tissue, where they are protected from the shear
stress of circulating blood.
Our results suggest that the actions of chemoattractants, such
as LTB4 and C5a, and cytokines may be additive in promoting
monocyte-mesangial cell adhesion during glomerular inflamma-
tion. GM-CSF is a cytokine produced by many hemopoietic
cells, including monocytes and mesangial cells, that provokes
adhesion of phagocytes to endothelial cells through CD1 1/
CD 18-dependent [33], and probably L-selectin-mediated mech-
anisms [41]. In the present study, GM-CSF (100 pM) provoked
monocyte adhesion to monolayers of mesangial cells and these
events were also inhibited, in large part, by anti-CD18 mAb.
Interestingly, GM-CSF, when used at concentrations of 1.0
pM, did not provoke adhesion, but appeared to prime mono-
cytes to the actions of LTB4 and C5a (Fig. 4). Furthermore,
significantly more mesangial cell injury, as determined by
51chromium release, was observed during coincubations of
chemoattractant-stimulated monocytes and mesangial cells, if
monocytes had been primed with this cytokine (Fig. 4), These
data are consistent with previous studies which demonstrate
that a variety of phagocyte responses, including lipoxygenase
product [34] and superoxide anion generation [35], are aug-
mented by prior exposure of phagocytes to GM-CSF. The
mechanism(s) by which GM-CSF primes phagocyte responses
have not been fully elucidated. However, this cytokine has
been shown to provoke upregulation of receptors for chemoat-
tractant peptides, and may modulate the function pertussis-
toxin sensitive G proteins in chemoattractant-linked leukocyte
signal transduction pathways [35]. The adhesion promoting
actions of LTB4 and C5a were also additive with those of TNF
and IL-I with mesangial cells. Since both TNF and IL-l have
been shown to induce de novo synthesis of mesangial cell
adhesion molecules, it seems reasonable to conclude that these
cytokines amplified the adhesion responses in the present study
by providing more mesangial cell ligands for monocyte binding.
Based on the findings presented in these and previous studies
[20, 21, 36], it appears that phagocyte-mesangial cell adhesion,
like phagocyte-endothelial cell adhesion, is subject to different
types of regulation. Phagocyte-directed stimuli, such as LTB4
and C5a provoke rapid phagocyte-mesangial cell adhesion by
CD1 l/CD18 and ICAM-l dependent and independent mecha-
nisms. In contrast, leukotriene D4 (LTD4) increases mesangial
cell adhesiveness for neutrophils [20] and monocytes (HRB,
unpublished observation) within minutes of exposure, an action
that can be inhibited, in part, by prior exposure of mesangial
cells to lipoxins [20]. LTD4-induced adhesion appears to be
CD1 l/CD18 independent [20], and the molecular basis for this
interaction has yet to be determined. Finally, as alluded to
above, prolonged exposure of mesangial cells to TNF and IL-l
increases mesangial cell adhesiveness for phagocytes by induc-
ing de novo synthesis of ICAM-l and VCAM-l, but not
E-selectin [21, 36]. It is noteworthy, however, that mesangial
cells support adhesion of neutrophils and monocytes in vitro
[20, 23]. Thus, the profile of mesangial cell adhesion molecule
expression cannot, by itself, account for the predominance of
monocytes over neutrophils in the mesangium during glomeru-
lar inflammation. It is likely that the numbers of monocytes and
neutrophils at different sites within glomeruli are a function of
the pattern of adhesion molecule expression on resident gb-
merular cells, and the combined actions of locally-generated
stimuli and inhibitors of neutrophil and monocyte chemotaxis
and adhesion. Further definition of these events may reveal
sites for pharmacologic intervention.
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